The newspaper El Periódico de Catalunya reports on the study by Miquel Coll, group leader of the Structural Biology of Proteins and Nucleic Acids, and Their Complexes Laboratory at IRB Barcelona, who has found a second use for an existing drug. The AIDS drug 'Isentress' could also be used against herpesviruses, which cause various diseases, some of which are very serious. "The inhibitor is not toxic at therapeutic levels for humans because it is already on the market, which should facilitate the testing of toxicity," says Miquel Coll.

• Read the news (PDF in Spanish)
• El Periódico de Catalunya Online